Discovery of biomarkers for immune-mediated liver disease.
- Conditions
- autoimmune hepatitis, drug-induced liver injury, non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
- Registration Number
- NL-OMON24228
- Lead Sponsor
- Investigator initiated study, funded by the Vrije Universiteit, University Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Indication for a biopsy for the diagnosis or monitoring of; AIH, DILI, NAFL or NASH
Eligible for liver biopsy
Exclusion Criteria
Contraindication for liver biopsy, determined by the clinician.
Current infectious disease.
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Immunophenotype of intrahepatic leucocytes.
- Secondary Outcome Measures
Name Time Method Histology outcome